Amisometradine-d3

CAS : 550-28-7

Ref. 3D-AAA55028

Informations sur le produit

• Nom: Amisometradine-d3
• Synonymes: 1-Methallyl-3-methyl-6-aminotetrahydropyrimidinedione, 2,4(1H,3H)-Pyrimidinedione, 6-amino-3-methyl-1-(2-methyl-2-propen-1-yl)-, 2,4(1H,3H)-Pyrimidinedione, 6-amino-3-methyl-1-(2-methyl-2-propenyl)-, 6-Amino-1-methallyl-3-methylpyrimidine-2,4-dione, 6-Amino-3-methyl-1-(2-methyl-2-propen-1-yl)-2,4(1H,3H)-pyrimidinedione, 6-Amino-3-methyl-1-(2-methylallyl)-2,4(1H,3H)-pyrimidinedione, 6-Amino-3-methyl-1-(2-methylallyl)uracil, 6-amino-3-methyl-1-(2-methylprop-2-en-1-yl)pyrimidine-2,4(1H,3H)-dione, 6-amino-3-methyl-1-methylallylpyrimidine-2,4(1H,3H)-dione, Aminoisometradin, Aminoisometradine, Amisometradin, NSC 70479, Rolicton, Uracil, 6-amino-3-methyl-1-(2-methylallyl)-

Description

Amisometradine-d3 is a beta-blocker medication that belongs to the class of non-selective beta blockers. It is used to treat high blood pressure, congestive heart failure, and angina pectoris. Amisometradine-d3 blocks the action of the enzyme phosphodiesterase, which then prevents the breakdown of cyclic AMP (cAMP). This results in an increase in cAMP levels in cardiac muscle cells. The increased cAMP levels result in relaxation of the myocardial muscles, which can reduce the workload on the heart and lower blood pressure. Amisometradine-d3 also has a lipophilic profile that allows it to cross cell membranes and act on cardiac tissue by binding to collagen molecules or other proteins involved in contraction.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 198.24 g/mol
• Formule: C₉H₁₀D₃N₃O₂
• Degré de pureté: Min. 95%